Glenmark Pharmaceuticals will launch a generic version of Ropivacaine Hydrochloride injection for local anesthesia in the US.
Glenmark Pharma to launch generic Ropivacaine Hydrochloride injection for local anesthesia in the US. Distribution starts November 2025.
Along with the boxed warning, FDA will require a statement on product labeling indicating that TXA injection is contraindicated as a neuraxial injection, and have the dose and administration section ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback